Sofinnova Investments, Inc. Q1 2018 Filing
Filed May 15, 2018
Portfolio Value
$581.8B
Holdings
53
Report Date
Q1 2018
Filing Type
13F-HR
All Holdings (53 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ASNDAscendis Pharma A/S | 2,479,514 | $162.2B | 27.87% | |
| 2 | —NuCana plc | 4,666,666 | $88.3B | 15.17% | |
| 3 | —ObsEva SA | 4,749,623 | $64.1B | 11.02% | |
| 4 | —Audentes Therapeutics | 1,380,303 | $41.5B | 7.13% | |
| 5 | MRUSMerus N.V. | 1,961,039 | $36.3B | 6.25% | |
| 6 | —Spark Therapeutics, Inc. | 481,270 | $32.0B | 5.51% | |
| 7 | CHRSCoherus BioSciences, Inc. | 2,893,221 | $32.0B | 5.49% | |
| 8 | NTRANatera, Inc. | 3,100,560 | $28.7B | 4.94% | |
| 9 | ACRSAclaris Therapeutics, Inc. | 1,539,480 | $27.0B | 4.64% | |
| 10 | APLSApellis Pharmaceuticals, Inc | 911,752 | $20.2B | 3.46% | |
| 11 | AMRNAmarin Corp PLC | 3,321,588 | $10.0B | 1.72% | |
| 12 | —Histogenics Corporation | 2,077,040 | $5.7B | 0.98% | |
| 13 | —Synlogic, Inc. | 574,972 | $5.4B | 0.93% | |
| 14 | —aTyr Pharma Inc | 1,866,126 | $4.9B | 0.85% | |
| 15 | —Edge Therapeutics, Inc. | 2,852,711 | $3.4B | 0.58% | |
| 16 | —Chiasma, Inc. | 1,630,221 | $2.4B | 0.42% | |
| 17 | —Allergan plc | 9,379 | $1.6B | 0.27% | |
| 18 | —Auris Medical Holding AG | 781,818 | $1.3B | 0.22% | |
| 19 | ALXNAlexion Pharmaceuticals, Inc. | 9,126 | $1.0B | 0.17% | |
| 20 | BMYBristol-Myers Squibb Company | 15,033 | $951.0M | 0.16% | |
| 21 | HRTXHeron Therapeutics, Inc. | 30,133 | $832.0M | 0.14% | |
| 22 | —Kadmon Holdings, Inc. | 186,774 | $794.0M | 0.14% | |
| 23 | AZNAstraZeneca PLC | 21,832 | $763.0M | 0.13% | |
| 24 | PTCTPTC Therapeutics, Inc. | 25,729 | $696.0M | 0.12% | |
| 25 | —Aimmune Therapeutics, Inc. | 20,308 | $646.0M | 0.11% | |
| 26 | —Radius Health Inc. | 16,847 | $605.0M | 0.10% | |
| 27 | RETAEURReata Pharmaceuticals Inc | 29,383 | $603.0M | 0.10% | |
| 28 | IOVAIovance Biotherapeutics, Inc. | 30,958 | $523.0M | 0.09% | |
| 29 | ARDXArdelyx, Inc. | 99,166 | $501.0M | 0.09% | |
| 30 | REGNRegeneron Pharmaceuticals, Inc. | 1,304 | $449.0M | 0.08% | |
| 31 | OTICEUROtonomy, Inc. | 98,624 | $414.0M | 0.07% | |
| 32 | —GW Pharmaceuticals PLC | 3,637 | $410.0M | 0.07% | |
| 33 | —Adamas Pharmaceuticals, Inc. | 16,206 | $387.0M | 0.07% | |
| 34 | —Dermira, Inc. | 48,320 | $386.0M | 0.07% | |
| 35 | CLSDUSDClearside Biomedical, Inc. | 35,379 | $380.0M | 0.07% | |
| 36 | ISIIonis Pharmaceuticals, Inc. | 8,476 | $374.0M | 0.06% | |
| 37 | —Foamix Pharmaceuticals Ltd. | 72,017 | $369.0M | 0.06% | |
| 38 | RIGLUSDRigel Pharmaceuticals, Inc. | 102,974 | $365.0M | 0.06% | |
| 39 | CPRXCatalyst Pharmaceuticals, Inc. | 148,055 | $354.0M | 0.06% | |
| 40 | MNOVMediciNova, Inc. | 32,875 | $336.0M | 0.06% | |
| 41 | KALAKala Pharmaceuticals, Inc. | 20,409 | $323.0M | 0.06% | |
| 42 | MRTXEURMirati Therapeutics, Inc. | 8,688 | $267.0M | 0.05% | |
| 43 | RIGLUSDRigel Pharmaceuticals, Inc | 71,300 | $252.0M | 0.04% | Put |
| 44 | SPPIUSDSpectrum Pharmaceuticals Inc. | 15,000 | $241.0M | 0.04% | Call |
| 45 | —OncoMed Pharmaceuticals, Inc. | 67,033 | $213.0M | 0.04% | |
| 46 | EX9Exelixis Inc | 9,300 | $206.0M | 0.04% | Call |
| 47 | —Affimed N.V. | 110,834 | $205.0M | 0.04% | |
| 48 | —Sierra Oncology, Inc. | 98,126 | $203.0M | 0.03% | |
| 49 | —Stemline Therapeutics INC | 12,640 | $193.0M | 0.03% | |
| 50 | SNDXSyndax Pharmaceuticals, Inc. | 12,124 | $173.0M | 0.03% | |
| 51 | —Aduro Biotech, Inc. | 16,694 | $155.0M | 0.03% | |
| 52 | —Calithera Biosciences, Inc. | 19,928 | $126.0M | 0.02% | |
| 53 | —OncoSec Medical Incorporated | 66,965 | $126.0M | 0.02% | |
| 54 | —Cidara Therapeutics, Inc. | 12,952 | $52.0M | 0.01% |